Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Neurotransmitters01:31

Neurotransmitters

Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-omic modeling of antidepressant response implicates dynamic immune and inflammatory changes in individuals who respond to treatment.

PloS one·2023
Same author

Adolescent anxiety and pain problems: A joint, genome-wide investigation and pathway-based analysis.

PloS one·2023
Same author

Transcriptional dissection of symptomatic profiles across the brain of men and women with depression.

bioRxiv : the preprint server for biology·2023
Same author

Genes implicated by a methylome-wide schizophrenia study in neonatal blood show differential expression in adult brain samples.

Molecular psychiatry·2023
Same author

The basolateral amygdala-anterior cingulate pathway contributes to depression-like behaviors and comorbidity with chronic pain behaviors in male mice.

Nature communications·2023
Same author

CDK10, CDK11, FOXO1, and FOXO3 Gene Expression in Alzheimer's Disease Encephalic Samples.

Cellular and molecular neurobiology·2023

Related Experiment Video

Updated: Jul 6, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Implication of the polyamine system in mental disorders.

Laura M Fiori1, Gustavo Turecki

  • 1McGill Group for Suicide Studies, Douglas Mental Health University Institute, McGill University, Montréal, Que., Canada.

Journal of Psychiatry & Neuroscience : JPN
|March 12, 2008
PubMed
Summary

The polyamine pathway is crucial for cellular functions and mental health. Its alterations link to psychiatric disorders like schizophrenia and mood disorders, offering potential for new neuropharmacological treatments.

Keywords:
depressionmental disorderspolyaminesschizophreniastresssuicide

More Related Videos

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Related Experiment Videos

Last Updated: Jul 6, 2026

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Area of Science:

  • Neurobiology
  • Biochemistry
  • Psychiatry

Background:

  • The polyamine pathway is vital for cellular functions.
  • Emerging evidence links the polyamine system to mental health disorders.
  • Polyamines and their metabolic enzymes are implicated in psychiatric conditions.

Purpose of the Study:

  • To explore the role of the polyamine pathway in the etiology and pathology of mental disorders.
  • To investigate polyamine system alterations in conditions such as schizophrenia, mood disorders, anxiety, and suicidal behavior.
  • To assess the potential of the polyamine pathway as a target for novel neuropharmacological treatments.

Main Methods:

  • Analysis of polyamine metabolic enzyme expression and activity.
  • Quantification of individual polyamine levels in relevant biological samples.
  • Review of existing literature on polyamine pathway involvement in psychiatric disorders and treatment responses.

Main Results:

  • Observed alterations in polyamine metabolic enzyme expression and activity in various mental disorders.
  • Detected changes in individual polyamine levels associated with schizophrenia, mood disorders, anxiety, and suicidal behavior.
  • Noted that polyamine pathway components are affected by psychiatric treatments.
  • Demonstrated antidepressant and anxiolytic effects of polyamines and their precursors.

Conclusions:

  • The polyamine pathway plays a significant role in the development and progression of mental disorders.
  • Alterations in polyamine metabolism are characteristic of several psychiatric conditions.
  • The polyamine pathway presents a promising target for developing innovative neuropharmacological therapies for mental health conditions.